Contrary, we confirmed that high expression of EMT-related and EMT–inducible proteins, high expression of DTX-metabolizing CYP1B1 and increased Caveolin-1 in BC-PDMs predict DTX resistance [82, 83, 124, 125]. This evidence concerns the gene CYP1B1 and breast cancer.